FDA advisors vote against effectiveness of Biogen’s ALS drug for rare and aggressive form of the disease - Earth News Report
In this articleBIIBFollow your favorite stocksCREATE FREE ACCOUNT A pedestrian walks past Biogen Inc. headquarters in Cambridge, Massachusetts, U.S., on Monday, June 7, 2021.Adam Glanzman | Bloomberg | Getty Images The Food and Drug Administration's independent panel of advisors on Wednesday voted against the effectiveness of Biogen's investigational ALS drug for a rare and aggressive
